Reviewing Solesence (SLSN) & The Competition

Solesence (NASDAQ:SLSN) is one of 55 public companies in the “Personal Care Products” industry, but how does it contrast to its rivals? We will compare Solesence to related businesses based on the strength of its risk, valuation, profitability, earnings, analyst recommendations, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings for Solesence and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1	0	0	0	1.00
Solesence Competitors	835	2790	3566	212	2.43

As a group, “Personal Care Products” companies have a potential upside of 3.54%. Given Solesence’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Solesence has less favorable growth aspects than its rivals.

Profitability

This table compares Solesence and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Solesence	1.56%	5.39%	1.78%
Solesence Competitors	-6.20%	-113.36%	-0.21%

Insider and Institutional Ownership

70.2% of Solesence shares are owned by institutional investors. Comparatively, 48.1% of shares of all “Personal Care Products” companies are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Comparatively, 12.2% of shares of all “Personal Care Products” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Solesence has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Solesence’s rivals have a beta of 0.79, suggesting that their average share price is 21% less volatile than the S&P 500.

Valuation & Earnings

This table compares Solesence and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Solesence	$62.06 million	$1.79 million	107.00
Solesence Competitors	$7.91 billion	$1.08 billion	2.64

Solesence’s rivals have higher revenue and earnings than Solesence. Solesence is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Solesence rivals beat Solesence on 7 of the 13 factors compared.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.